Conversely, immune activation via homeostatic proliferation is important for the rejection of tumors and IL-21 administration may inhibit the progression of metastatic melanoma and renal carcinoma in clinical protocols [60], [61]. The gene discussed is IL21; the disease is metastatic melanoma.